Market Research Logo

Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2016

Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2016’, provides an overview of the Hanmi Pharmaceuticals, Co. Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Hanmi Pharmaceuticals, Co. Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Hanmi Pharmaceuticals, Co. Ltd.
  • The report provides overview of Hanmi Pharmaceuticals, Co. Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Hanmi Pharmaceuticals, Co. Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Hanmi Pharmaceuticals, Co. Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Hanmi Pharmaceuticals, Co. Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Hanmi Pharmaceuticals, Co. Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Hanmi Pharmaceuticals, Co. Ltd.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Introduction
Global Markets Direct Report Coverage
Hanmi Pharmaceuticals, Co. Ltd. Snapshot
Hanmi Pharmaceuticals, Co. Ltd. Overview
Key Information
Key Facts
Hanmi Pharmaceuticals, Co. Ltd. - Research and Development Overview
Key Therapeutic Areas
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Products Glance
Hanmi Pharmaceuticals, Co. Ltd. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Hanmi Pharmaceuticals, Co. Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Hanmi Pharmaceuticals, Co. Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Hanmi Pharmaceuticals, Co. Ltd. - Drug Profiles
HCP-1302
Product Description
Mechanism of Action
R&D Progress
(HM30181A + paclitaxel)
Product Description
Mechanism of Action
R&D Progress
eflapegrastim
Product Description
Mechanism of Action
R&D Progress
HCP-1105
Product Description
Mechanism of Action
R&D Progress
HCP-1303
Product Description
Mechanism of Action
R&D Progress
HCP-1305
Product Description
Mechanism of Action
R&D Progress
HCP-1401
Product Description
Mechanism of Action
R&D Progress
HGP-0816
Product Description
Mechanism of Action
R&D Progress
HGP-1207
Product Description
Mechanism of Action
R&D Progress
HIP-1402
Product Description
Mechanism of Action
R&D Progress
ALG-1001
Product Description
Mechanism of Action
R&D Progress
efpegsomatropin
Product Description
Mechanism of Action
R&D Progress
olmutinib
Product Description
Mechanism of Action
R&D Progress
poziotinib
Product Description
Mechanism of Action
R&D Progress
KX-01
Product Description
Mechanism of Action
R&D Progress
(HM30181A + irinotecan hydrochloride)
Product Description
Mechanism of Action
R&D Progress
amlodipine besylate
Product Description
Mechanism of Action
R&D Progress
HCP-1202
Product Description
Mechanism of Action
R&D Progress
HCP-1405
Product Description
Mechanism of Action
R&D Progress
HM-12525A
Product Description
Mechanism of Action
R&D Progress
HM-71224
Product Description
Mechanism of Action
R&D Progress
HM-95573
Product Description
Mechanism of Action
R&D Progress
BH-03004
Product Description
Mechanism of Action
R&D Progress
Biologics for Diabetes
Product Description
Mechanism of Action
R&D Progress
Biologics for Obesity
Product Description
Mechanism of Action
R&D Progress
Small Molecules 1 for Autoimmune Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecules 2 for Autoimmune Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Acute Myeloid Leukemia
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Fibrosis and Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Oncology
Product Description
Mechanism of Action
R&D Progress
Biologics to Target CTLA4 and TNF Alpha
Product Description
Mechanism of Action
R&D Progress
Biologics to Target HER2 and CD3
Product Description
Mechanism of Action
R&D Progress
Biologics to Target HER2 and VEGFR
Product Description
Mechanism of Action
R&D Progress
HM-12260B
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Target ROR Gamma
Product Description
Mechanism of Action
R&D Progress
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Analysis
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Products by Target
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Products by Route of Administration
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Products by Molecule Type
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Products by Mechanism of Action
Hanmi Pharmaceuticals, Co. Ltd. - Recent Pipeline Updates
Hanmi Pharmaceuticals, Co. Ltd. - Dormant Projects
Hanmi Pharmaceuticals, Co. Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Hanmi Pharmaceuticals, Co. Ltd., Key Information
Hanmi Pharmaceuticals, Co. Ltd., Key Facts
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Indication, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Stage of Development, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Monotherapy Products in Pipeline, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Combination Treatment Modalities in Pipeline, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Partnered Products in Pipeline, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Partnered Products/ Combination Treatment Modalities, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Out-Licensed Products in Pipeline, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pre-Registration, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Phase III, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Phase II, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Phase I, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Preclinical, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Discovery, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Target, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Route of Administration, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Molecule Type, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Products by Mechanism of Action, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Recent Pipeline Updates, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Dormant Developmental Projects,2016
Hanmi Pharmaceuticals, Co. Ltd., Other Locations
Hanmi Pharmaceuticals, Co. Ltd., Subsidiaries
List of Figures
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Top 10 Indication, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Stage of Development, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Monotherapy Products in Pipeline, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Combination Treatment Modalities in Pipeline, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Partnered Products in Pipeline, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Out-Licensed Products in Pipeline, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Top 10 Target, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Route of Administration, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline by Molecule Type, 2016
Hanmi Pharmaceuticals, Co. Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report